U.S. Proposal Targets Recovery of $9 Billion a Year in Medicare Advantage Payments
Key Facts
The Centers for Medicare & Medicaid Services on November 16, 2026, issued a proposal to strengthen program integrity oversight across Medicare, Medicaid, the Children’s Health Insurance Program and the health insurance marketplace, estimating that expanded audits of Medicare Advantage plans could allow the recovery of an average of nearly $9 billion for each payment year. The text proposes applying audit findings beginning with audits for payment year 2018, broadening the range of years that claims could cover. The agency said these amounts are estimates of potential recoveries, not funds it has announced collecting. The proposal puts reforms to risk-adjustment data validation at the center of measures to combat overpayments to Medicare Advantage plans. It also addresses fraud reporting and provider enrollment, along with other provisions involving federal health insurance programs.
CMS says its Risk Adjustment Data Validation program is its primary tool for addressing overpayments to Medicare Advantage organizations. The audit tests whether medical records support the diagnoses plans use to adjust payments for beneficiaries’ risk. The text proposes codifying the exclusion of the fee-for-service adjuster, along with specifying an appropriate sampling methodology. CMS says improper inflation of risk scores is associated with $21 billion in overpayments annually. In fiscal year 2025 estimates, based on calendar year 2023 payments, excess Part C payments exceeded $21 billion, or more than 5% of total Part C payments. The proposed extrapolation would begin with payment year 2018 audits, while CMS continues auditing more recent years; selected plans were notified of payment year 2024 audits in August 2026, and the agency announced the start of payment year 2021 and 2020 audits in May and March of the same year.
The proposal aims to expand case reporting alongside record audits. In calendar year 2025, 46% of Part C and D plan contracts reported suspected or confirmed fraud referrals, while only 19% reported payment suspensions based on credible fraud allegations. CMS proposes making referrals for suspected or confirmed fraud, waste and abuse mandatory for Medicare Advantage organizations and Part D sponsors. It also proposes expanding payment-suspension reporting to include other types of providers and suppliers. This would broaden the reporting requirements in the proposal at a time when 2025 data showed variation among contracts in referrals and suspensions. The measures are tied to efforts to strengthen CMS’s ability to track suspected fraud and the actions plans take.
The proposal also covers enrollment requirements for providers and suppliers that bill Medicare Advantage plans. CMS proposes requiring eligible categories to enroll in Original Medicare with an approved status, with an exception for Programs of All-Inclusive Care for the Elderly plans. If adopted, the requirement would begin on the first day of the plan year that starts after two years from publication of the final rule. That means the implementation date would be tied to issuance of the final version and the start of the specified plan year, rather than the proposal’s publication date. The package also includes Medicaid and the health insurance marketplace, giving it a broader scope than the Medicare Advantage audit mechanism alone. CMS says it intends to issue program integrity rules of this kind annually.
CMS estimates that the proposal’s quantified provisions would cost about $379 million over the period from 2027 to 2036. That estimate excludes more than $90 billion in projected transfers between the federal government and states or private entities; the text describes them as transfers, not federal budget savings. CMS said the Office of the Actuary had not completed a quantitative assessment of the rule’s effect on the federal budget or trust funds. It added that more detailed estimates would appear in the final rule and requested comments on the accuracy of its estimates. Against this backdrop, CMS said Medicare integrity savings rose from $26.3 billion in fiscal year 2024 to a record $41.9 billion in fiscal year 2025, an increase of 59%. The return on investment in the Medicare Integrity Program was 22.3 to 1 in fiscal year 2025.
The proposal could have implications for insurers and care providers, according to analyst assessments cited by Reuters via Benzinga. TD Cowen analysts described its impact as negative for Medicare Advantage plans and modestly negative for insurers offering Medicaid plans and home-care providers. The analysts said the measures add potential exposure that could extend over a long period and end in legal disputes. Oppenheimer analysts said expected recoveries could be concentrated in the 2028–2030 period. They added that the higher recovery estimate reflects the expanded scope of audits, and noted the proposal could face legal challenges similar to those CMS faced in 2025. The recovery estimate does not identify any individual company’s share.
The proposal follows a request for information issued by CMS on February 27, 2026, to which it received more than 560 comments and suggestions, some of which it said helped shape the rule. It set January 19, 2027, as the deadline for public comments on the proposal. The text is scheduled for publication in the Federal Register on November 19, 2026. After the comment period ends, the proposed measures will still need to complete the rulemaking process and be issued in final form. The final version will set out the adopted provisions and detailed estimates, while the start of the provider enrollment requirement will be tied to two years after its publication and the start of the relevant plan year.